Qilu Hospital of Shandong University
π¨π³China
- Country
- π¨π³China
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.qiluhospital.com
Intercalated Combination of Chemotherapy and Tyrosine Kinase Inhibitors as First-line Treatment for Patients With Non-Small-Cell Lung Cancer
Phase 4
- Conditions
- Non-Small-Cell Lung Cancer
- Interventions
- First Posted Date
- 2014-01-09
- Last Posted Date
- 2016-03-29
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 250
- Registration Number
- NCT02031601
- Locations
- π¨π³
Yu Li, Jinan, Shandong, China
Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling
Completed
- Conditions
- Left Ventricular RemodelingMyocardial InfarctionmiR-126
- First Posted Date
- 2013-06-11
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Qilu Hospital of Shandong University
- Target Recruit Count
- 1200
- Registration Number
- NCT01875484
- Locations
- π¨π³
The Second Hospital of Shandong University, Jinan, Shandong, China
π¨π³The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
π¨π³Affiliated Hospital of Binzhou Medical Universty, Binzhou, Shandong, China
Β© Copyright 2025. All Rights Reserved by MedPath